Matrix Trust Company’s Eastman Chemical EMN Stock Holding History

Matrix Trust Company’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-297	Closed	-$19K	–	208
2025 Q4	$19K	Buy	+297	New	+$18.3K	﹤0.01%	158

Other funds holding EMN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Matrix Trust Company's EMN Position: Q1 2026 in Review

Matrix Trust Company sold out of Eastman Chemical (EMN) in Q1 2026, closing a stake of 297 shares — an estimated $19K sold.

Matrix Trust Company first reported a position in EMN in Q4 2025 and held it in 1 quarter. The position peaked at $19K in Q4 2025. 635 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

Matrix Trust Company reported no remaining Eastman Chemical position as of Q1 2026 after selling out during the quarter.
Matrix Trust Company sold 297 Eastman Chemical shares in Q1 2026, an estimated $19K.
Matrix Trust Company first reported a position in Eastman Chemical in Q4 2025 and held it in 1 quarter.
Matrix Trust Company's Eastman Chemical position peaked at $19K in Q4 2025.
635 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Matrix Trust Company's 13F filing for Q1 2026, filed 10 Apr 2026.